GTHX — G1 Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for G1 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	269	207	221	145	82.2
Net Total Accounts Receivable
Net Total Receivables	—	0.237	5.69	11.1	12.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	271	216	244	180	115
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.4	10.5	9.05	7.95	6.38
Other Long Term Assets
Total Assets	285	229	254	188	122
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.8	23.4	27.6	35.6	29.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	29.3	51.2	111	119	86.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	256	177	144	68.7	35.4
Total Liabilities & Shareholders' Equity	285	229	254	188	122
Total Common Shares Outstanding